FAQ'S
Pick and click on your question and you’ll get a quick answer.
- What is Ananda Labs?
- What is epigenetic reprogramming?
- What is RPER technology?
- What conditions can Ananda Labs’ therapies treat?
- How does Ananda Labs’ skin rejuvenation therapy work?
- What are fibroblasts?
- What is the goal of Ananda Labs’ hair rejuvenation research?
- How does Ananda Labs’ vision restoration therapy work?
- What is age-related macular degeneration (AMD)?
- How does Ananda Labs’ immune system rejuvenation work?
- Is Ananda Labs’ technology safe?
- Who developed the RPER technology?
- Where is Ananda Labs headquartered?
- What are the long-term goals of Ananda Labs?
- What sets Ananda Labs apart from its competitors?
- Can I invest in Ananda Labs?
- Is Ananda Labs involved in any collaborations?
- What is the science behind epigenetic aging?
- What is the potential impact of Ananda Labs’ therapies?
- What are some of the current projects at Ananda Labs?
- How does Ananda Labs’ technology differ from Yamanaka factors?
- What is the epigenetic clock?
- What are the applications of Ananda Labs’ technology?
- How does Ananda Labs ensure the effectiveness of its therapies?
- What is the future vision for Ananda Labs?
- Can I use Ananda Labs’ therapies at home?
- What role does the placenta play in Ananda Labs’ technology?
- How does Ananda Labs measure success?
- Are Ananda Labs’ therapies available to the public?
- How can I learn more about Ananda Labs?
- Im a non US entity ,can I invest in Ananda Labs?
- Are you planing an IPO
- What are your gene delivery vehicles, the target cells, and how you would apply the target cells.
1. What is Ananda Labs?
Answer: Ananda Labs is a biotechnology company focused on developing advanced therapies for reversing aging and treating age-related diseases through epigenetic reprogramming technology.
2. What is epigenetic reprogramming?
Answer: Epigenetic reprogramming is a process that alters gene expression without changing the underlying DNA sequence. Ananda Labs utilizes this approach to reverse aging at the cellular level while maintaining the identity and functionality of the cells.
3. What is RPER technology?
Answer: RPER (Rejuvenation-based Placental Epigenetic Reprogramming) is Ananda Labs’ proprietary technology that uses patented placental and embryonic factors to rejuvenate aged cells, reversing their biological age by up to 50%.
4. What conditions can Ananda Labs' therapies treat?
Answer: Ananda Labs’ therapies target a range of age-related conditions including wrinkles, skin damage, hair loss, age-related macular degeneration (AMD), and immune system decline.
5. How does Ananda Labs' skin rejuvenation therapy work?
Answer: The therapy involves isolating a patient’s skin fibroblasts, rejuvenating them using RPER technology, and reinserting them into the skin to restore elasticity and reduce wrinkles.
6. What are fibroblasts?
Answer: Fibroblasts are skin cells responsible for maintaining skin structure by producing collagen, hyaluronic acid and Elastin. As we age, their function declines, leading to wrinkles and skin sagging.
7. What is the goal of Ananda Labs' hair rejuvenation research?
Answer: The goal is to develop therapies that reverse hair loss and restore natural hair color by rejuvenating hair follicle cells using the RPER technology.
8. What is age-related macular degeneration (AMD)?
Answer: AMD is a condition that causes central vision loss due to the deterioration of the macula, a part of the retina. It primarily affects older adults.
9. How does Ananda Labs' vision restoration therapy work?
Answer: The therapy aims to treat AMD by rejuvenating retinal cells using RPER technology, potentially restoring vision and preventing blindness.
10. How does Ananda Labs' immune system rejuvenation work?
Answer: The therapy targets the rejuvenation of immune cells, potentially reducing the risk of age-related diseases such as cancer, Alzheimer’s, and Parkinson’s.
11. Is Ananda Labs' technology safe?
Answer: Ananda Labs’ technology is designed to be safer than existing reprogramming methods by avoiding the risks associated with altering DNA and focusing on enhancing gene expression.
12. Who developed the RPER technology?
Answer: The RPER technology was developed by Prof. Yosef Buganim, a leading expert in stem cells and reprogramming, in partnership with Ananda Labs.
13. Where is Ananda Labs headquartered?
Answer: Ananda Labs is headquartered in New York City, with additional offices in Tel-Aviv, Israel, and planned expansions in Orange County, California.
14. What are the long-term goals of Ananda Labs?
Answer: The long-term goals include developing affordable, accessible anti-aging therapies that address root causes of age-related diseases and conditions.
15. What sets Ananda Labs apart from its competitors?
Answer: Ananda Labs has developed a unique, patented set of factors that are safer and more effective than other reprogramming technologies, giving them a competitive advantage in the anti-aging field.
16. Can I invest in Ananda Labs?
Answer: Yes, Ananda Labs is currently raising funds and offers opportunities for accredited investors to participate in their pioneering work, for more information contact us info@ananda-labs.com.
17. Is Ananda Labs involved in any collaborations?
Answer: Ananda Labs is open to partnerships with biotech, lifestyle, and cosmetic companies to enhance research and development in combating degenerative diseases and age-related conditions.
18. What is the science behind epigenetic aging?
Answer: Epigenetic aging involves changes in the epigenome that reduce a cell’s ability to respond to environmental cues, leading to inappropriate gene expression and age-related decline.
19. What is the potential impact of Ananda Labs' therapies?
Answer: The potential impact includes significantly extending healthy lifespans, reducing the incidence of age-related diseases, improving appearance, and enhancing the quality of life for older adults and those who are becoming older
20. What are some of the current projects at Ananda Labs?
Answer: Current projects include skin fibroblast rejuvenation, hair loss reversal, vision restoration for AMD, and immune system rejuvenation.
21. How does Ananda Labs' technology differ from Yamanaka factors?
Answer: Ananda Labs’ technology is designed to avoid the tumorigenic risks associated with Yamanaka factors by using safer, more targeted reprogramming factors.
22. What is the epigenetic clock?
Answer: The epigenetic clock is a measure of a cell’s age based on changes in the epigenome, which can be reversed through targeted reprogramming.
23. What are the applications of Ananda Labs' technology?
Answer: Applications include anti-aging therapies, treatment of degenerative diseases, and potentially reversing cellular aging across various organ systems.
24. How does Ananda Labs ensure the effectiveness of its therapies?
Answer: Ananda Labs’ therapies are based on extensive preclinical research and are continuously optimized for safety and effectiveness.
25. What is the future vision for Ananda Labs?
Answer: The vision is to democratize anti-aging medicine, making it affordable and accessible to the broader population, not just the elite.
26. Can I use Ananda Labs' therapies at home?
Answer: Ananda Labs is aiming to develp a topical cream for ongoing skin rejuvenation that patients can use at home as a complement to clinical treatments.
27. What role does the placenta play in Ananda Labs' technology?
Answer: The placenta plays a key role as a source of potent factors used in the RPER technology to rejuvenate cells.
28. How does Ananda Labs measure success?
Answer: Success is measured by the ability to reverse cellular aging, restore function in aging tissues, and ultimately improve patient outcomes.
29. Are Ananda Labs' therapies available to the public?
Answer: Currently, Ananda Labs is in the research and development stage, with plans to make therapies available following clinical validation and regulatory approval.
30. How can I learn more about Ananda Labs?
Answer: You can learn more by visiting Ananda Labs’ official website,www.ananda-labs.bio,on FaceBook https://www.facebook.com/anandalabsinc,Linkedin https://www.linkedin.com/company/ananda-labs-inc/posts reading our publications, or contacting us directly for specific inquiries.
31. Im a non US entity ,can I invest in Ananda Labs?
Yes. contact us
32. Are you planing an IPO
Yes.
33. What are your gene delivery vehicles, the target cells, and how you would apply the target cells.
Answers:
A. Age-related Macular Degeneration (AMD):We plan to inject clinical-grade AAVs encoding the reprogramming factors directly into the eye. The specific AAV serotype has already been calibrated in the lab. We’re collaborating with ophthalmologists at Hadassah hospital who routinely perform this injection technique.
B. Skin:We will take a biopsy from behind the patient’s ear, expand the cells in the lab, and deliver the factors using modified RNAs to control their expression. Our long-term goal is to develop a topical lotion that can deliver the factors directly to the dermis.
C. Immune System: We intend to isolate CD34+ cells from peripheral blood and introduce the factors using clinical-grade AAVs. The serotype for this has also been calibrated in the lab.
34. Where is your technology coming from?
Answer: Ten Years of research: Since 2014, the Hebrew University of Jerusalem has studied and developed a unique patented set of factors/genes that can rejuvenate cells, which are believed to be superior to those of our competitors. Prof. Yosef Buganim, a world leader in the field of stem cells and reprogramming, was the first to discover a combination of genes that can convert adult cells into placental stem cells. Given that the chronological age of the placenta is zero (embryonic stage), Prof. Buganim’s method can also rejuvenate cells through site-specific alteration of epigenetic marks.
His research demonstrated that this combination of factors is particularly potent in targeting the genome of adult cells, achieving up to 50% age reversal in adult skin cells while preserving their identity. This age reversal was associated with improved function and healthier cells. Moreover, unlike Yamanaka factors, which carry a tumorigenic risk (formation of teratoma, a benign tumor), Prof. Buganim’s combination is safer.
